Enveric Biosciences (ENVB) Stock Price, Quote, News & History

Key Statistics

Open

$3.43

$3.37

Volume / Avg.

4.53M / 3.06M

Day Range

$2.99 - $3.56

52 Wk Range

1.71 - 17.84

Market Cap

$6.67M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.64%

Days to Cover

2.22

Recent Enveric Biosciences Inc News

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Enveric BioSciences Inc. shares are soaring on Monday after President Trump order to accelerate approvals for psychedelic treatments.

Evette Mitkov

Trump Administration Eyes Ibogaine Research For PTSD Treatment, Stock Jumps

Trump administration eyes ibogaine research for PTSD and addiction, despite safety concerns and Schedule I classification.

Vandana Singh

Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested

Gilgamesh withdraws patent challenge against Enveric, leaving the key psilocybin patent uncontested.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.14M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

10.58M

Free Cash Flow (TTM)

-8.14M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

2.44M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.57M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

1.72

Earnings Yield % (TTM)

-1001.10%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.10

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$4.68M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$3.43

$3.37

Volume / Avg.

4.53M / 3.06M

Day Range

$2.99 - $3.56

52 Wk Range

1.71 - 17.84

Market Cap

$6.67M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.64%

Days to Cover

2.22

About

Sector

Health Care

Industry

Pharmaceuticals

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003,...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry